Merck Serono Venture Fund: Fresh funding for early stage deals
In what has proven to be a turbulent period for the biotech industry since Merck Serono launched its corporate venture fund in March, one deal has been announced, and Bulthuis hinted he may have news to discuss at BIO-Europe 2009 when he participates in the panel discussion “Funding Early Stage Programs in Difficult Times.”
Read more »